niclosamide has been researched along with Graft vs Host Disease in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morin, F | 1 |
| Kavian, N | 1 |
| Nicco, C | 1 |
| Cerles, O | 1 |
| Chéreau, C | 1 |
| Batteux, F | 1 |
1 other study available for niclosamide and Graft vs Host Disease
| Article | Year |
|---|---|
Improvement of Sclerodermatous Graft-Versus-Host Disease in Mice by Niclosamide.
Topics: Animals; B-Lymphocytes; Cytokines; Disease Models, Animal; Flow Cytometry; Graft vs Host Disease; Im | 2016 |